Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population.
Marconi M, Pagano MT, Ristori J, Bonadonna S, Pivonello R, Meriggiola MC, Motta G, Lombardo F, Mosconi M, Oppo A, Cocchetti C, Romani A, Federici S, Bruno L, Verde N, Lami A, Crespi CM, Marinelli L, Giordani L, Matarrese P, Ruocco A, Santangelo C, Contoli B, Masocco M, Minardi V, Chiarotti F, Fisher AD, Pierdominici M. Marconi M, et al. Among authors: matarrese p. J Endocrinol Invest. 2024 May 11. doi: 10.1007/s40618-024-02362-x. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38733428
Estimate and needs of the transgender adult population: the SPoT study.
Fisher AD, Marconi M, Castellini G, Safer JD, D'Arienzo S, Levi M, Brogonzoli L, Iardino R, Cocchetti C, Romani A, Mazzoli F, Matarrese P, Ricca V, Vignozzi L, Maggi M, Pierdominici M, Ristori J. Fisher AD, et al. Among authors: matarrese p. J Endocrinol Invest. 2024 Feb 19. doi: 10.1007/s40618-023-02251-9. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38372939
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2.
Abbruzzese C, Matteoni S, Matarrese P, Signore M, Ascione B, Iessi E, Gurtner A, Sacconi A, Ricci-Vitiani L, Pallini R, Pace A, Villani V, Polo A, Costantini S, Budillon A, Ciliberto G, Paggi MG. Abbruzzese C, et al. Among authors: matarrese p. Cell Death Dis. 2023 Dec 13;14(12):821. doi: 10.1038/s41419-023-06353-3. Cell Death Dis. 2023. PMID: 38092755 Free PMC article.
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.
Fragale A, Stellacci E, Romagnoli G, Licursi V, Parlato S, Canini I, Remedi G, Buoncervello M, Matarrese P, Pedace L, Ascione B, Pizzi S, Tartaglia M, D'Atri S, Presutti C, Capone I, Gabriele L. Fragale A, et al. Among authors: matarrese p. Int J Cancer. 2023 Sep 1;153(5):1080-1095. doi: 10.1002/ijc.34602. Epub 2023 Jun 9. Int J Cancer. 2023. PMID: 37293858
Inhibition of cholesterol transport impairs Cav-1 trafficking and small extracellular vesicles secretion, promoting amphisome formation in melanoma cells.
Peruzzu D, Boussadia Z, Fratini F, Spadaro F, Bertuccini L, Sanchez M, Carollo M, Matarrese P, Falchi M, Iosi F, Raggi C, Parolini I, Carè A, Sargiacomo M, Gagliardi MC, Fecchi K. Peruzzu D, et al. Among authors: matarrese p. Traffic. 2023 Feb;24(2):76-94. doi: 10.1111/tra.12878. Epub 2023 Jan 6. Traffic. 2023. PMID: 36519961 Free article.
181 results